GlassScriptPhysician profile
Craig A Backous
NPI 1073713418
$7,462.19
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $556 · 2020: $443 · 2021: $736 · 2022: $874 · 2023: $669 · 2024: $4,184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Food and Beverage: $1,228 · Travel and Lodging: $1,124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Food and Beverage | $1,228.25 |
| Travel and Lodging | $1,124.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,640.12 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $519.72 | 2019-2023 | Tezspire, Fasenra, Airsupra |
| Regeneron Healthcare Solutions, INC. | $435.34 | 2021-2024 | Dupixent |
| Genzyme Corporation | $409.61 | 2021-2024 | |
| Glaxosmithkline, LLC. | $364.83 | 2019-2024 | Trelegy Ellipta, Arexvy |
| Abbvie INC. | $319.92 | 2022-2024 | Dalvance, Avycaz |
| Pfizer INC. | $223.36 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $185.24 | 2019-2022 | |
| Electromed, INC. | $175.57 | 2019-2024 | Smartvest |
| Vapotherm INC | $174.07 | 2021-2023 | Vapotherm |
| Janssen Pharmaceuticals, INC | $170.07 | 2021-2023 | Opsumit |
| Genentech USA, INC. | $155.94 | 2019-2024 | Xolair |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.44 | 2019-2023 | Stiolto Respimat, Spiriva Respimat |
| Allergan, INC. | $75.39 | 2020 | |
| Pulmonx Corporation | $69.92 | 2019-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inogen, INC. | $66.95 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Boston Scientific Corporation | $62.92 | 2020 | |
| Insmed, INC. | $49.49 | 2021-2024 | Arikayce |
| Jazz Pharmaceuticals INC. | $38.27 | 2019-2022 | |
| Baxter Healthcare | $35.51 | 2022 | |
| Covis Pharma Gmbh | $29.61 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.52 | 2021 | |
| Philips North America LLC | $28.04 | 2024 | (Ak6) Vest Therapy |
| E.R. Squibb & Sons, L.L.C. | $18.21 | 2021 | |
| Merck Sharp & Dohme LLC | $17.39 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $15.29 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.86 | 2019 | |
| Sunovion Pharmaceuticals INC. | $14.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Backous listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.